The Case for Biomarker Testing in Gastroesophageal Cancer The Case for Biomarker Testing in Gastroesophageal Cancer

To take advantage of the latest targeted therapies in gastroesophageal cancer, physicians needed to identify patients who will benefit, but biomarker testing in this population continued to lag.Medscape Medical News
Source: Medscape Pathology Headlines - Category: Pathology Tags: Hematology-Oncology Source Type: news